Genosera Inc.
PrivateLast Round
Grant
Jul 31, 2023
Total Funding Raised
$150,000
Company Overview
Genosera Inc. is a biotechnology company that develops proprietary dual-gene AAV gene therapy treatments for rare neuromuscular and genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genosera Inc. Comparables
Compare Genosera Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Atamyo Therapeutics | 82% | |
| Bayer AG | 73% | |
| Solid Biosciences Inc. | 68% | |
Genosera Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 31, 2023 | ||||
| Grant | Jul 11, 2023 |
Genosera Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio Third Frontier | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2023
Received grant funding from Solve GNE.
Genosera Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genosera Inc.'s valuation, stock price, and market status.